Regencell Bioscience RGC Stock
$8.59
20.476858%
Add to favorites
SECTOR
COUNTRY
Exchange
Market Cap
$4.26B
LOW - HIGH [24H]
$7.08
-
$8.65
VOLUME [24H]
$373.31K
P/E Ratio
0
Earnings per share
-$0.02
ISIN
KYG7487R1002
Regencell Bioscience Price Chart
Regencell Bioscience RGC Financial and Trading Overview
| Regencell Bioscience stock price | 8.59 USD |
| Previous Close | 7.35 USD |
| Open | 7.23 USD |
| Bid | 5.19 USD x 200 |
| Ask | 8.8 USD x 200 |
| Day's Range | 6.82 - 7.37 USD |
| 52 Week Range | 4.51 - 69 USD |
| Volume | 97.06K USD |
| Avg. Volume | 195.53K USD |
| Market Cap | 3.52B USD |
| Beta (5Y Monthly) | 1.166 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.02 USD |
| Forward Dividend & Yield | N/A (0%) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
RGC Valuation Measures
| Enterprise Value | 3.63B USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 3547.4998 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -311.834 |
Trading Information
Regencell Bioscience Stock Price History
| Beta (5Y Monthly) | 1.166 |
| 52-Week Change | -59.14% |
| S&P500 52-Week Change | 17.38% |
| 52 Week High | 69 USD |
| 52 Week Low | 4.51 USD |
| 50-Day Moving Average | 5.96 USD |
| 200-Day Moving Average | 18.87 USD |
RGC Share Statistics
| Avg. Volume (3 month) | 195.53K USD |
| Avg. Daily Volume (10-Days) | 173.83K USD |
| Shares Outstanding | 495.88M |
| Float | 55.62M |
| Short Ratio | 3.95 |
| % Held by Insiders | 88.30% |
| % Held by Institutions | 0.28% |
| Shares Short | 656.18K |
| Short % of Float | 1.15% |
| Short % of Shares Outstanding | 0.13% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | 38:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2026 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | June 30, 2027 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -71.54% |
| Return on Equity (ttm) | -128.52% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -11643553 USD |
| Net Income Avi to Common (ttm) | -11701941 USD |
| Diluted EPS (ttm) | -0.02 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 14.19M USD |
| Total Cash Per Share (mrq) | 0.03 USD |
| Total Debt (mrq) | 295.81K USD |
| Total Debt/Equity (mrq) | 2.22 USD |
| Current Ratio (mrq) | 10.769 |
| Book Value Per Share (mrq) | 0.002 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -7695530 USD |
| Levered Free Cash Flow (ttm) | -2989076 USD |
Profile of Regencell Bioscience
| Country | United States |
| State | N/A |
| City | Causeway Bay |
| Address | Chinachem Leighton Plaza |
| ZIP | N/A |
| Phone | 852 2155 0823 |
| Website | https://www.regencellbioscience.com |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 10 |
Regencell Bioscience Holdings Limited focuses on the research, development, and commercialization of Traditional Chinese Medicine (TCM) in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, TCM brain theory, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Q&A For Regencell Bioscience Stock
What is a current RGC stock price?
Regencell Bioscience RGC stock price today per share is 8.59 USD.
How to purchase Regencell Bioscience stock?
You can buy RGC shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Regencell Bioscience?
The stock symbol or ticker of Regencell Bioscience is RGC.
Which industry does the Regencell Bioscience company belong to?
The Regencell Bioscience industry is Drug Manufacturers - Specialty & Generic.
How many shares does Regencell Bioscience have in circulation?
The max supply of Regencell Bioscience shares is 495.88M.
What is Regencell Bioscience Price to Earnings Ratio (PE Ratio)?
Regencell Bioscience PE Ratio is now.
What was Regencell Bioscience earnings per share over the trailing 12 months (TTM)?
Regencell Bioscience EPS is -0.02 USD over the trailing 12 months.
Which sector does the Regencell Bioscience company belong to?
The Regencell Bioscience sector is Healthcare.
Regencell Bioscience RGC included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
27171.93 USD — |
-0.27
|
3.92B USD — | 27116.08 USD — | 27277.88 USD — | — - | 3.92B USD — |
|
NYSE Composite Index
NYA
US
|
23962.46 USD — |
-0.12
|
— — | 23897.52 USD — | 24067.61 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1286.56 USD — |
-1.75
|
— — | 1286 USD — | 1306.24 USD — | — - | — — |
- {{ link.label }} {{link}}
